1. Home
  2. CNTB vs AIFU Comparison

CNTB vs AIFU Comparison

Compare CNTB & AIFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • AIFU
  • Stock Information
  • Founded
  • CNTB 2012
  • AIFU 1998
  • Country
  • CNTB United States
  • AIFU China
  • Employees
  • CNTB N/A
  • AIFU N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • AIFU
  • Sector
  • CNTB Health Care
  • AIFU
  • Exchange
  • CNTB Nasdaq
  • AIFU NYSE
  • Market Cap
  • CNTB 53.9M
  • AIFU 61.0M
  • IPO Year
  • CNTB 2021
  • AIFU 2007
  • Fundamental
  • Price
  • CNTB $1.05
  • AIFU $0.39
  • Analyst Decision
  • CNTB Strong Buy
  • AIFU
  • Analyst Count
  • CNTB 1
  • AIFU 0
  • Target Price
  • CNTB $8.00
  • AIFU N/A
  • AVG Volume (30 Days)
  • CNTB 28.0K
  • AIFU 1.4M
  • Earning Date
  • CNTB 09-05-2024
  • AIFU 09-18-2024
  • Dividend Yield
  • CNTB N/A
  • AIFU N/A
  • EPS Growth
  • CNTB N/A
  • AIFU N/A
  • EPS
  • CNTB N/A
  • AIFU 0.38
  • Revenue
  • CNTB $24,116,000.00
  • AIFU $324,923,970.00
  • Revenue This Year
  • CNTB N/A
  • AIFU N/A
  • Revenue Next Year
  • CNTB $63.90
  • AIFU $11.81
  • P/E Ratio
  • CNTB N/A
  • AIFU $1.02
  • Revenue Growth
  • CNTB N/A
  • AIFU N/A
  • 52 Week Low
  • CNTB $0.90
  • AIFU $0.33
  • 52 Week High
  • CNTB $2.66
  • AIFU $6.59
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 45.74
  • AIFU N/A
  • Support Level
  • CNTB $1.01
  • AIFU N/A
  • Resistance Level
  • CNTB $1.40
  • AIFU N/A
  • Average True Range (ATR)
  • CNTB 0.13
  • AIFU 0.00
  • MACD
  • CNTB -0.01
  • AIFU 0.00
  • Stochastic Oscillator
  • CNTB 25.53
  • AIFU 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIX Inc is a technology-driven financial services provider company in China. It is an intelligent platform that creates a supportive and collaborative environment and provides solutions that integrate technology, products, services, operations, capital, and professional support for individual agents and sales organizations. The group uses technology, AI, and data-driven insights, pioneering the financial services that are delivered, its transformation, and empowering industry development. It connects customers with financial institutions, investment opportunities, and service providers, offering insurance, wealth management, and other value-added services.

Share on Social Networks: